Click here - to use the wp menu builder

Sun Pharma inks licensing pact with SPARC to commercialise medication in US market

By: The Bengaluru Live

Date:

November 9, 2022 2:26 PM

Drug major Sun Pharma on Wednesday said it has inked a licensing agreement with Sun Pharma Advanced Research Company to commercialise a medication for the treatment of neonatal seizures in the US market.

Previous article

Palestinians say teen dies after Israeli raid in West Bank

Next article

Bengaluru gears up to become India’s first Arogya City

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here

Share post:

Subscribe

spot_img

spot_img

Popular

More like this
Related

{"prefetch":[{"source":"document","where":{"and":[{"href_matches":"\/*"},{"not":{"href_matches":["\/wp-*.php","\/wp-admin\/*","\/wp-content\/uploads\/*","\/wp-content\/*","\/wp-content\/plugins\/*","\/wp-content\/themes\/thebengalurulive\/*","\/*\\?(.+)"]}},{"not":{"selector_matches":"a[rel~=\"nofollow\"]"}},{"not":{"selector_matches":".no-prefetch, .no-prefetch a"}}]},"eagerness":"conservative"}]}